+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lymphoma Drugs Market Research Reports

Global Non-Hodgkin Lymphoma Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Non-Hodgkin Lymphoma Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
US Non-Hodgkin Lymphoma Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Non-Hodgkin Lymphoma Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Hodgkin Lymphoma Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Hodgkin Lymphoma Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Asia Pacific Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

Asia Pacific Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 111 Pages
  • Asia Pacific
From
LAMEA Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

LAMEA Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 111 Pages
  • Africa, Middle East
From
Europe Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

Europe Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 110 Pages
  • Europe
From
North America Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

North America Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 100 Pages
  • North America
From
Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Regional Outlook and Forecast, 2023-2029 - Product Thumbnail Image

Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Regional Outlook and Forecast, 2023-2029

  • Report
  • April 2023
  • 260 Pages
  • Global
From
T-Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

T-Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 263 Pages
  • Global
From
Peripheral T-Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Peripheral T-Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 165 Pages
  • Global
From
Saudi Arabia Thymus Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Saudi Arabia Thymus Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • December 2021
  • 40 Pages
  • Saudi Arabia
From
India Thymus Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

India Thymus Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • December 2021
  • 40 Pages
  • India
From
Africa Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Africa Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • January 2022
  • 80 Pages
  • Africa
From
India Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

India Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • January 2022
  • 40 Pages
  • India
From
Saudi Arabia Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Saudi Arabia Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • January 2022
  • 40 Pages
  • Saudi Arabia
From
Lymphoma Treatment Drugs Markets in China - Product Thumbnail Image

Lymphoma Treatment Drugs Markets in China

  • Report
  • November 2023
  • 206 Pages
  • China
From
CAR T-Cell Therapy Market, By Type (Abecma, Breyanzi, Kymriah, Tecartus, Yescarta), End-user (Hospitals, Specialty Clinics, Others), Application (Cancer, Lymphoma, Others), Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2028 - Product Thumbnail Image

CAR T-Cell Therapy Market, By Type (Abecma, Breyanzi, Kymriah, Tecartus, Yescarta), End-user (Hospitals, Specialty Clinics, Others), Application (Cancer, Lymphoma, Others), Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2028

  • Report
  • June 2022
  • 220 Pages
  • Global
From
Treanda - API Insight, 2022 - Product Thumbnail Image

Treanda - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Velcade - API Insight, 2022 - Product Thumbnail Image

Velcade - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Beleodaq - API Insight, 2022 - Product Thumbnail Image

Beleodaq - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Lymphoma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat lymphoma, a type of cancer that affects the lymphatic system. These drugs are used to reduce the size of tumors, reduce symptoms, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is the most common form of treatment for lymphoma, and involves the use of drugs to kill cancer cells. Targeted therapy is a newer form of treatment that uses drugs to target specific cancer cells, while immunotherapy uses drugs to stimulate the body's own immune system to fight the cancer. The Lymphoma Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more